Buprenorphine and Naloxone
NDC 3215-6523, buprenorphine and naloxone, film, from Aveva Drug Delivery Systems Inc..
- Product NDC
- 3215-6523
- Status
- Listed
- Labeler
- Aveva Drug Delivery Systems Inc.
- Dosage form
- FILM
- Route
- BUCCAL, SUBLINGUAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212756
- DEA schedule
- CIII
curl https://api.healthcare.dev/v1/drugs/ndc/3215-6523 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUPRENORPHINE HYDROCHLORIDE8 mg/1
- NALOXONE HYDROCHLORIDE2 mg/1
Pharmacologic classes
Opioid Antagonist [EPC]; Opioid Antagonists [MoA]; Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 3215-6523-30 | 03215652330 | 30 POUCH in 1 CARTON (3215-6523-30) / 1 FILM in 1 POUCH (3215-6523-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/cb112448-49a1-4209-bcdb-7cfae6501f51
Use it
Look up 3215-6523 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/3215-6523 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 3215-6523. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.